Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2015 Nov 19;158:94–101. doi: 10.1016/j.drugalcdep.2015.11.008

Table 1.

Demographic and clinical characteristics of study sample, by alcohol risk group.

Nondrinker n=357,086 Low-risk drinking n=156,928 Moderate-risk drinking n = 58,149 High-risk drinking n=7167 Total n=579,330
Age, mean (SD) 77.4 (7.4) 76.6 (7.3) 76.6 (7.3) 71.1 (6.0) 77.0 (7.4)
Male, n (%) 350,171(98.1%) 154,903(98.7%) 57,324(98.6%) 7149(99.7%) 569,547(98.3%)
Race, n (%)
 White 300,743(84.2%) 139,499(88.9%) 53,628(92.2%) 6011(83.9%) 499,881(86.3%)
 Nonwhite 56,343(15.8%) 17,429(11.1%) 4521(7.8%) 1156(16.1%) 79,449(13.7%)
Marital status, n (%)
 Unmarried 122,557(34.3%) 50,326(32.1%) 19,259(33.1%) 3944(55.0%) 196,086(33.8%)
 Married 233,301(65.3%) 106,084(67.6%) 38,642(66.5%) 3202(44.7%) 381,229(65.8%)
 Missing/unknown 1228(0.3%) 518(0.3%) 248(0.4%) 21(0.3%) 2015(0.3%)
Copay exempt status, n (%)
 Copay required 99,657(27.9%) 62,095(39.6%) 25,087(43.1%) 1679(23.4%) 188,518(32.5%)
 Copay exempt 255,174(71.5%) 93,883(59.8%) 32,728(56.3%) 5444(76.0%) 387,229(66.8%)
 Missing/unknown 2255(0.6%) 950(0.6%) 334(0.6%) 44(0.6%) 3583(0.6%)
Tobacco, n (%) 47,292(13.2%) 22,620(14.4%) 10,888(18.7%) 3218(44.9%) 84,018(14.5%)
PTSD, n (%) 19,842(5.6%) 7053(4.5%) 2207(3.8%) 681(9.5%) 29,783(5.1%)
AUD, n (%) 10,245(2.9%) 7422(4.7%) 9314(16.0%) 4412(61.6%) 31,393(5.4%)
Comorbidity index, mean (SD)a 3.7 (3.0) 3.2 (2.9) 3.1 (2.8) 3.3 (2.7) 3.5 (2.9)
Past-yr hospitalizations, mean (SD) 0.5 (1.0) 0.3 (0.8) 0.3 (0.8) 0.5 (1.1) 0.4 (0.9)
Past-yr ED visits, mean (SD) 1.2 (2.0) 0.8 (1.6) 0.8 (1.5) 1.3 (2.4) 1.0 (1.9)
Index length of Stay, mean (SD) 4.0 (3.6) 3.7 (3.3) 3.7 (3.4) 4.4 (4.1) 3.9 (3.5)
Any AMA, n (%) 2145(0.6%) 755(0.5%) 301(0.5%) 150(2.1%) 3351(0.6%)

Note: Differences across the four AUDIT-C groups were statistically significant for all characteristics in this table (p< 0.001), based on Chi-square tests for categorical variables and analysis of variance for continuous variables.

a

Prevalence of specific comorbid conditions included in primary analyses available in Appendix 2.